Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Santiago Palacios, Claus Christiansen, Rafael Sánchez Borrego, Marco Gambacciani, Payman Hadji, Morten Karsdal, Irene Lambrinoudaki, Stefano Lello, Barbara O’Beirne, Fatima Romao, Serge Rozenberg, John C. Stevenson & Zion Ben-Rafael. (2012) Recommendations on the management of fragility fracture risk in women younger than 70 years. Gynecological Endocrinology 28:10, pages 770-786.
Read now
Read now
Cheng T Tee, Katharina Wallis & Simon M Gabe. (2011) Emerging treatment options for short bowel syndrome: potential role of teduglutide. Clinical and Experimental Gastroenterology 4, pages 189-196.
Read now
Read now
Kishore Vipperla & Stephen J O’Keefe. (2011) Teduglutide for the treatment of short bowel syndrome. Expert Review of Gastroenterology & Hepatology 5:6, pages 665-678.
Read now
Read now
Jørn Brynskov. (2008) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 43:11, pages 1283-1284.
Read now
Read now
Articles from other publishers (31)
Sarina Gadgaard, Johanne A. Windeløv, Sine P. Schiellerup, Jens J. Holst, Bolette Hartmann & Mette M. Rosenkilde. (2023) Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system. Biomedicine & Pharmacotherapy 160, pages 114383.
Crossref
Crossref
Henrik Maagensen, Mads M. Helsted, Lærke S. Gasbjerg, Tina Vilsbøll & Filip K. Knop. (2022) The Gut-Bone Axis in Diabetes. Current Osteoporosis Reports 21:1, pages 21-31.
Crossref
Crossref
Sarina Gadgaard, Wijnand J. C. Velden, Sine P. Schiellerup, Jenna Elizabeth Hunt, Maria B. N. Gabe, Johanne Agerlin Windeløv, Geke Aline Boer, Hannelouise Kissow, Cathrine Ørskov, Jens J. Holst, Bolette Hartmann & Mette M. Rosenkilde. (2022) Novel agonist and antagonist radioligands for the GLP‐2 receptor. Useful tools for studies of basic GLP‐2 receptor pharmacology. British Journal of Pharmacology 179:9, pages 1998-2015.
Crossref
Crossref
Aleksandra Mieczkowska, Beatrice Bouvard, Erick Legrand & Guillaume Mabilleau. (2021) [Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures. Frontiers in Endocrinology 12.
Crossref
Crossref
Kirsa Skov‐Jeppesen, Nicola Hepp, Jannika Oeke, Morten Steen Hansen, Abbas Jafari, Maria Saur Svane, Nariman Balenga, John A OlsonJrJr, Morten Frost, Moustapha Kassem, Sten Madsbad, Jens‐Erik Beck Jensen, Jens Juul Holst, Mette Marie Rosenkilde & Bolette Hartmann. (2021)
The Antiresorptive Effect of
GIP
, But Not
GLP
‐2, Is Preserved in Patients With Hypoparathyroidism—A Randomized Crossover Study
. Journal of Bone and Mineral Research 36:8, pages 1448-1458.
Crossref
Crossref
Vanessa D. Sherk, Irene Schauer & Viral N. Shah. (2020) Update on the Acute Effects of Glucose, Insulin, and Incretins on Bone Turnover In Vivo. Current Osteoporosis Reports 18:4, pages 371-377.
Crossref
Crossref
Rasmus Fuglsang-Nielsen, Elin Rakvaag, Peter Vestergaard, Bolette Hartmann, Jens Juul Holst, Kjeld Hermansen, Søren Gregersen & Jakob Starup-Linde. (2020) Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity. Bone 133, pages 115230.
Crossref
Crossref
Kirsa Skov-Jeppesen, Maria S. Svane, Christoffer Martinussen, Maria B.N. Gabe, Lærke S. Gasbjerg, Simon Veedfald, Kirstine N. Bojsen-Møller, Sten Madsbad, Jens J. Holst, Mette M. Rosenkilde & Bolette Hartmann. (2019) GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men. Bone 125, pages 178-185.
Crossref
Crossref
Sine Paasch Schiellerup, Kirsa Skov-Jeppesen, Johanne Agerlin Windeløv, Maria Saur Svane, Jens Juul Holst, Bolette Hartmann & Mette Marie Rosenkilde. (2019) Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment. Frontiers in Endocrinology 10.
Crossref
Crossref
Patricia L. Brubaker. 2011. Comprehensive Physiology. Comprehensive Physiology
1185
1210
.
Alyce M. Martin, Richard L. Young, Lex Leong, Geraint B. Rogers, Nick J. Spencer, Claire F. Jessup & Damien J. Keating. (2017) The Diverse Metabolic Roles of Peripheral Serotonin. Endocrinology 158:5, pages 1049-1063.
Crossref
Crossref
Custon Nyabanga, Gursimran Kochhar, Guilherme Costa, Basem Soliman, Bo Shen & Kareem Abu-Elmagd. (2016) Management of Crohnʼs Disease in the New Era of Gut Rehabilitation and Intestinal Transplantation. Inflammatory Bowel Diseases 22:7, pages 1763-1776.
Crossref
Crossref
Laura S Girão Lopes, Rubens Prado Schwartz, Bruno Ferraz-de-Souza, Maria Elizabeth Rossi da Silva, Pedro Henrique Silveira Corrêa & Márcia Nery. (2015) The role of enteric hormone GLP-2 in the response of bone markers to a mixed meal in postmenopausal women with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome 7:1.
Crossref
Crossref
A. Palermo, L. D’Onofrio, R. Eastell, A. V. Schwartz, P. Pozzilli & N. Napoli. (2015) Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review. Osteoporosis International 26:8, pages 2073-2089.
Crossref
Crossref
Kareem Abu-Elmagd. (2015) The concept of gut rehabilitation and the future of visceral transplantation. Nature Reviews Gastroenterology & Hepatology 12:2, pages 108-120.
Crossref
Crossref
Alfonso Vidal Casariego, María Dolores Ballesteros Pomar & Isidoro Cano Rodríguez. 2014. El hueso en las enfermedades endocrinas y nutricionales. El hueso en las enfermedades endocrinas y nutricionales
261
268
.
M. Dibb, A. Teubner, V. Theis, J. Shaffer & S. Lal. (2013) Review article: the management of long‐term parenteral nutrition. Alimentary Pharmacology & Therapeutics 37:6, pages 587-603.
Crossref
Crossref
Carsten Askov-Hansen, Palle B. Jeppesen, Pernille Lund, Bolette Hartmann, Jens J. Holst & Dennis B. Henriksen. (2013) Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure. Regulatory Peptides 181, pages 4-8.
Crossref
Crossref
Paula H. Stern. 2013. Osteoporosis. Osteoporosis
71
93
.
F Folli, B N Sabowitz, W Schwesinger, P Fanti, R Guardado-Mendoza & G Muscogiuri. (2012) Bariatric surgery and bone disease: from clinical perspective to molecular insights. International Journal of Obesity 36:11, pages 1373-1379.
Crossref
Crossref
Ilaria Dicembrini, Edoardo Mannucci & Carlo Maria Rotella. (2012) Bone: Incretin Hormones Perceiver or Receiver?. Experimental Diabetes Research 2012, pages 1-5.
Crossref
Crossref
K. Henriksen, J. Bollerslev, V. Everts & M. A. Karsdal. (2011) Osteoclast Activity and Subtypes as a Function of Physiology and Pathology—Implications for Future Treatments of Osteoporosis. Endocrine Reviews 32:1, pages 31-63.
Crossref
Crossref
Cong Yu, Shujun Jiang, Jianyun Lu, Carrie C. Coughlin, Yuan Wang, Elzbieta A. Swietlicki, Lihua Wang, Ilja Vietor, Lukas A. Huber, Domagoj Cikes, Trey Coleman, Yan Xie, Clay F. Semenkovich, Nicholas O. Davidson, Marc S. Levin & Deborah C. Rubin. (2010) Deletion of Tis7 Protects Mice from High-Fat Diet-Induced Weight Gain and Blunts the Intestinal Adaptive Response Postresection. The Journal of Nutrition 140:11, pages 1907-1914.
Crossref
Crossref
Jennifer S. Walsh & Dennis B. Henriksen. (2010) Feeding and bone. Archives of Biochemistry and Biophysics 503:1, pages 11-19.
Crossref
Crossref
J. Chris Gallagher & A.J. Sai. (2010) Molecular biology of bone remodeling: Implications for new therapeutic targets for osteoporosis. Maturitas 65:4, pages 301-307.
Crossref
Crossref
Monica H. Wojcik, Erinne Meenaghan, Elizabeth A. Lawson, Madhusmita Misra, Anne Klibanski & Karen K. Miller. (2010) Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. Bone 46:3, pages 796-800.
Crossref
Crossref
Iris PL Wong, Paul A Baldock & Herbert Herzog. (2010) Gastrointestinal peptides and bone health. Current Opinion in Endocrinology, Diabetes and Obesity 17:1, pages 44-50.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 16:6, pages 470-480.
Crossref
Crossref
Dennis B. Henriksen, Peter Alexandersen, Bolette Hartmann, Charlotte L. Adrian, Inger Byrjalsen, Henry G. Bone, Jens J. Holst & Claus Christiansen. (2009) Four-month treatment with GLP-2 significantly increases hip BMD. Bone 45:5, pages 833-842.
Crossref
Crossref
Katharina Wallis, Julian RF Walters & Simon Gabe. (2009) Short bowel syndrome: the role of GLP-2 on improving outcome. Current Opinion in Clinical Nutrition & Metabolic Care 12:5, pages 526-532.
Crossref
Crossref
J. S. Walsh & R. Eastell. (2009) Effects of Feeding on Bone Metabolism. Clinical Reviews in Bone and Mineral Metabolism 7:3, pages 230-239.
Crossref
Crossref